Journals / Çocuk Enfeksiyon Dergisi / 2011 / Cilt: 5 - Sayı: 3

Hemophagocytic Syndrome Associated with Visceral Leishmaniasis: Report of Two Cases

Viseral Leishmaniasis ile Birlikte Hemofagositik Sendrom: İki Olgu Sunumu

Pages
106–109
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Treatment with the pentavalant antimonials resulted in a dramatic resolution of all signs and symptoms within a few days.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Visceral leishmaniasis is a systemic infection of the reticuloendothelial system caused by protozoan parasites of the genus Leishmania.
📊
Key Findings & Data:It may mimic or lead to several types of hematological disorders including hemophagocytosis.
💡
Conclusion & Impact:Treatment with the pentavalant antimonials resulted in a dramatic resolution of all signs and symptoms within a few days.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Visceral leishmaniasis is a systemic infection of the reticuloendothelial system caused by protozoan parasites of the genus Leishmania. It may mimic or lead to several types of hematological disorders including hemophagocytosis. Hemophagocytic syndrome associated with visceral leishmaniasis is an extremely rare clinicopathological entitiy. This condition is often difficult to diagnose, so treatment is often delayed. In this article, two pediatric cases who were admitted with prolonged fever, hepatosplenomegaly and pancytopenia are presented. Laboratory testing of these patients also showed hyperferritinemia and hypofibrinogenemia. Bone marrow examination revealed hemophagocytosis and Leishmania amastigotes. Treatment with the pentavalant antimonials resulted in a dramatic resolution of all signs and symptoms within a few days.

Özet

Viseral leishmaniasis, Leishmania protozoonunun neden olduğu retiküloendoteliyal sistemin sistemik bir enfeksiyonudur. Hemofagositoz dahil birçok hematolojik hastalığa veya benzer tablolara neden olabilir. Hemofagositik sendromun Viseral leishmaniasis ile birlikteliği ise oldukça nadirdir. Bu durum sıklıkla tanıyı güçleştirir ve tedaviyi geciktirir. Bu makalede uzamış yüksek ateş, hepatosplenomegali ve pansitopeni ile başvuran iki olgu sunuldu. Bu olgularda ayrıca hiperferritinemi ve hipofibrinojenemi de mevcuttu. Kemik iliği incelemelerinde hemofagositoz ve Leishmania amastigotları görüldü. Beş değerli antimon bileşikleri ile yapılan tedaviler sonucu tüm bulgu ve semptomlarda birkaç gün içinde dramatik düzelme saptandı.

🔖

Cite This Article

DİNÇEL, N., HIZARCIOĞLU, M., GÜLEZ, P. (2022). Hemophagocytic Syndrome Associated with Visceral Leishmaniasis: Report of Two Cases. Çocuk Enfeksiyon Dergisi, Cilt: 5 - Sayı: 3, 106–109. https://ajindex.com/articles/484101

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Melby PC. Leishmaniasis. Behrman RE, Kliegman RM, Jenson HB, Stanton BF (eds). Nelson Textbook of Peditrics. 18th edition. Philadelphia: WB Saunders; 2007. p.1468-71
  2. Henter JI, Horne A, Arica M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr blood cancer 2007; 48: 124-31. [CrossRef] 3. Ok UZ, Balcıoğlu IC, Taylan Özkan A, Özensoy S, Özbel Y. Leishmaniasis in Turkey. Acta Trop 2002; 84: 43-8. [CrossRef] 4. Özensoy S, Özbel Y, Turgay N, et al. Serodiagnosis and epidemiology of visceral leishmaniasis in Turkey. Am J Trop Med Hyg 1998; 59: 363-9
  3. Özyürek E, Özçay F, Yılmaz B, Özbek N. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis: A case report. Pediatric Hematology and Oncology 2005; 22: 409-14. [CrossRef] 6. Gürgey A, Şeçmeer G, Tavil B, et al. Secondary hemophagocytic lymphohistiocytosis in Turkish children. Pediatr Infect Dis J 2005; 24: 1116-7
  4. Tapısız A, Belet N, Çitçi E, İnce E, Doğru Ü. Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis. Journal of Tropical Pediatrics 2007; 53: 359-61. [CrossRef] 8. Gagnaire MH, Galambrun C, Stephan JL. Hemophagocytic syndrome: a misleading complication of visceral leishmaniasis in children-a series of 12 cases. Pediatrics 2000; 106: 58. [CrossRef] 9. Mathur P, Samantaray JC, Samanta P. Fatal haemophagocytic syndrome and hepatitis associated with visceral leishmaniasis. Indian Journal of Medical Microbiology 2007; 25: 416-8. [CrossRef] 10. Coukell AJ, Brogden RN. Liposomal amphotericine B: therapeutic use in the management of fungal infections and visceral leishmanisis. Drugs 1998; 55: 585-612. [CrossRef] 11. Rajagopala S, Dutta U, Chandra K, Bhatia P, Varma N, Kochhar R. Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis: Case report and systematic review. Journal of Infection 2008; 56: 381-8. [CrossRef]